Yale Jen
Stock Analyst at Laidlaw & Co.
(0.09)
# 4,494
Out of 5,123 analysts
15
Total ratings
6.67%
Success rate
-18.29%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTN Palatin Technologies | Initiates: Buy | $60 | $16.05 | +273.83% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.49 | +1,240.21% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $6.00 | +266.67% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $0.82 | +508.12% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $39.58 | +165.29% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.45 | +124.85% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.54 | +1,742.30% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $110.71 | -56.64% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $4.56 | +10,316.67% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.90 | +11,742.11% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.49 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.29 | +3,384.32% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.34 | - | 1 | Aug 15, 2023 |
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $16.05
Upside: +273.83%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.49
Upside: +1,240.21%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $6.00
Upside: +266.67%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $0.82
Upside: +508.12%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $39.58
Upside: +165.29%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.45
Upside: +124.85%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.54
Upside: +1,742.30%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $110.71
Upside: -56.64%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $4.56
Upside: +10,316.67%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.90
Upside: +11,742.11%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.49
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.29
Upside: +3,384.32%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.34
Upside: -